title: Prasugrel Versus Ticagrelor: Uncertainty Remains.
authors.affiliation: From TIMI Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, MA.
authors.forename: Marc P
authors.initials: MP
authors.lastname: Bonaca
authors.affiliation: From TIMI Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, MA. swiviott@partners.org.
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Wiviott
mesh_terms: D054058:Acute Coronary Syndrome; D000241:Adenosine / Q000031:analogs & derivatives; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors; D000068799:Prasugrel Hydrochloride; D058921:Purinergic P2Y Receptor Antagonists; D000077486:Ticagrelor; D013988:Ticlopidine; D016896:Treatment Outcome; D035501:Uncertainty
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine
keywords: Editorials; P2Y12 inhibitor; acute coronary syndromes; antiplatelet; clinical trial; myocardial ischemia; stent